HighLife is a trans-catheter mitral valve replacement company.
HighLife has raised $90.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2026.
HighLife's investors include European Investment Bank, U.S. Venture Partners, Andera Partners, Supernova Invest, Sofinnova Partners.
HighLife is headquartered in Paris, France.
HighLife is a trans-catheter mitral valve replacement company.
HighLife is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"HighLife — Funding & Investors." VCBacked, September 22, 2026, https://www.vcbacked.co/company/highlife. Accessed October 1, 2026.
VCBacked. (2026). HighLife — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/highlife
{{cite web |title=HighLife — Funding & Investors |url=https://www.vcbacked.co/company/highlife |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated